Evidence map›Paper›PMID 38999437›Full record

ArticleJournal of clinical medicine2024

A New Histology-Based Prognostic Index for Aggressive T-Cell lymphoma: Preliminary Results of the "TCL Urayasu Classification".

Hideaki Nitta, Haruko Takizawa, Toru Mitsumori, Hiroko Iizuka-Honma, Tomonori Ochiai, Chiho Furuya, Yoshihiko Araki, Maki Fujishiro, Shigeki Tomita, Akane Hashizume and 6 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hideaki NittaDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.ORCID 0000-0002-1209-6594
Haruko TakizawaDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.
Toru MitsumoriDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.
Hiroko Iizuka-HonmaDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.
Tomonori OchiaiDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.ORCID 0000-0001-6156-4211
Chiho FuruyaDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.
Yoshihiko ArakiDepartment of Pathology and Microbiology, Division of Microbiology, Nippon University School of Medicine, Tokyo 113-8602, Japan.ORCID 0000-0002-4759-9765
Maki FujishiroInstitute for Environmental and Gender-Specific Medicine, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.
Shigeki TomitaDepartment of Diagnostic Pathology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.
Akane HashizumeDepartment of Diagnostic Pathology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.
Tomohiro SawadaDepartment of Clinical Laboratory, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.
Kazunori MiyakeDepartment of Clinical Laboratory, Faculty of Medical Sciences, Juntendo University, Tokyo 113-8421, Japan.
Mitsuo OkuboLaboratory of Blood Transfusion, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.ORCID 0000-0001-9098-4477
Yasunobu SekiguchiHematology Clinic, Saitama Cancer Center, Saitama 362-0806, Japan.
Miki AndoDivision of Hematology, Juntendo University Juntendo Hospital, Tokyo 113-0033, Japan.
Masaaki NoguchiDepartment of Hematology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi 279-0021, Japan.ORCID 0000-0001-9458-2707

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AKR1C3GRP78GRP94P53PD-1PD-L1PD-L2prognostic classificationTCLthymidine phosphorylase

Identifiers

PMID38999437
PMCPMC11242040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.